If there were any doubt remaining about the outlook for single cell gene expression, it vanished last fall with the National Institute for Health's (NIH's) announcement of a $90 million support of single cell gene studies and genomic sequencing.
On the forefront of this movement is NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, and BD Biosciences, a segment of BD, a global medical technology company, today announced a collaboration agreement for the development of a single cell isolation and analysis workflow.
Isolating Single Gene Cells
Image credits: Advance
Follow Art and Science of Laboratory Medicine on